← Open Payments lookup

SEVAN SAGHERIAN: Open Payments

NPI 1790253300 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$981 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $263 · 2025 $981

Food & beverage: $981
CompanyPaymentsAmount
Novo Nordisk Inc2$220
Insulet Corporation1$150
CeQur Corporation1$150
Abbott Laboratories1$133
Lilly USA, LLC1$109
Medtronic, Inc.1$102
Tandem Diabetes Care, Inc.3$95
Xeris Pharmaceuticals, Inc.1$22

Products named: Ozempic, OMNIPOD, CeQur Simplicity, FREESTYLE LIBRE 3, MOUNJARO, MINIMED 780G, t:slim X2 Insulin Pump with Control-IQ, GVOKE HYPOPEN.

Industry payments across PA — which companies pay providers there.